Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.
Mantovani G, Macciò A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G. Mantovani G, et al. Among authors: mudu mc. Oncol Rep. 1999 Nov-Dec;6(6):1425-30. doi: 10.3892/or.6.6.1425. Oncol Rep. 1999. PMID: 10523724 Clinical Trial.
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Mantovani G, Macciò A, Madeddu C, Mulas C, Massa E, Astara G, Ferreli L, Mudu MC, Gramignano G, Murgia V, Lusso MR, Mocci M, Cardia A, Mura L. Mantovani G, et al. Among authors: mudu mc. Oncol Rep. 2002 Jul-Aug;9(4):887-96. Oncol Rep. 2002. PMID: 12066227 Clinical Trial.
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Madeddu C, Mura L, Mudu MC, Proto E, Tore G, Mura M, Macciò A, Ferreli A, Amichetti M. Mantovani G, et al. Among authors: mudu mc. Oncol Rep. 2003 May-Jun;10(3):759-66. Oncol Rep. 2003. PMID: 12684655 Clinical Trial.
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A. Mantovani G, et al. Among authors: mudu mc. Int J Oncol. 2002 Feb;20(2):419-27. Int J Oncol. 2002. PMID: 11788911 Clinical Trial.
Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer.
Mantovani G, Macciò A, Lai P, Massa E, Massa D, Mulas C, Succu G, Mudu MC, Manca G, Versace R, Pisano A. Mantovani G, et al. Among authors: mudu mc. J Immunother. 2000 Mar-Apr;23(2):267-74. doi: 10.1097/00002371-200003000-00011. J Immunother. 2000. PMID: 10746553 Clinical Trial.
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.
Mantovani G, Maccio A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G. Mantovani G, et al. Among authors: mudu mc. Int J Oncol. 2000 Jun;16(6):1227-33. doi: 10.3892/ijo.16.6.1227. Int J Oncol. 2000. PMID: 10812000 Clinical Trial.
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.
Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Mulas C, Mudu MC, Murgia V, Camboni P, Massa E, Ferreli L, Contu P, Rinaldi A, Sanjust E, Atzei D, Elsener B. Mantovani G, et al. Among authors: mudu mc. Int J Cancer. 2002 Mar 1;98(1):84-91. doi: 10.1002/ijc.10143. Int J Cancer. 2002. PMID: 11857390
13 results